IOMED Raises €10M for International Expansion of its AI-Powered Technology for Healthcare Data Activation

IOMED, a leader in AI-powered technology for healthcare data activation, has recently announced the closure of a Series A investment round for a total of 10 million euros. The round was led by Philips Ventures and XTX Ventures, the venture capital arm of leading algorithmic trading company XTX Markets. Fondo Bolsa Social and Redseed also participated in the round, as well as IOMED’s existing investors Adara Ventures and EASO Ventures. The company has also received a grant of nearly €1 million from red.es to support a research and development project in artificial intelligence. This milestone represents the consolidation of the company as a leader in the healthcare technology sector and clear evidence of its unique value proposition. This funding round will enable IOMED to expand internationally, consolidate its position in the current market, and develop new business models based on the company’s sustainable growth. Gabriel Maeztu, IOMED’s Co-Founder, CTO, and Chairman of the Board said, “The lack of structured and standardized data in the healthcare sector has been a significant obstacle in its development for many decades. Thanks to the latest advances in artificial intelligence, we are at a turning point that will change the history of medicine.” Javier de Oca, Co-Founder and CEO at IOMED added, “At IOMED, our mission is to be the catalyst that drives a better future for the healthcare ecosystem through the application of Artificial Intellig...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Adara Ventures EASO Ventures Fondo Bolsa Social Gabriel Maeztu Health IT Funding Health IT Fundings Health IT Investment IOMED Javier de Oca KPMG Montserrat Roura Novartis Pedro Cladera Philips Source Type: blogs